Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Description | Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (Janssen-Cilag Ltd) |
BNF code | 0402020AABBACAC |
Virtual Medicinal Product | Risperidone 37.5mg powder and solvent for suspension for injection vials |
Name | Risperdal Consta 37.5mg powder and solvent for suspension for injection vials |
Abbreviated name | Risperdal Consta 37.5mg inj vials |
Date of name applicability | 9 Jun 2004 |
Previous name | Risperdal Consta 37.5mg injection vials and diluent |
Supplier | Janssen-Cilag Ltd |
Current licensing authority | Medicines - MHRA/EMA |
EMA additional monitoring | ✗ |
Parallel import | ✗ |
Restrictions on availability | None |
Licensed Route | |
---|---|
Licenced route | Intramuscular |
Actual Medicinal Product Packs | |
Risperdal Consta 37.5mg powder and solvent for suspension for injection vials (Janssen-Cilag Ltd) 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_3.3.0_20240325000001, imported on 27th March 2024 at 18:10:55.